Identification and validation of a selective small molecule inhibitor targeting the diacylglycerol acyltransferase 2 activity = 디아실글리세롤 아실트랜스퍼라제 선택적 억제물질 발굴 및 검증
Cited 33 time in
Metadata Downloads
Title
Identification and validation of a selective small molecule inhibitor targeting the diacylglycerol acyltransferase 2 activity = 디아실글리세롤 아실트랜스퍼라제 선택적 억제물질 발굴 및 검증
Biological & Pharmaceutical Bulletin, vol. 36, no. 7, pp. 1167-1173
Publication Year
2013
Abstract
Diacylglycerol acyltransferase 2 (DGAT2) is one of two distinct DGAT enzymes that catalyze the last step in triacylglycerol (TG) synthesis. Findings from previous studies suggest that inhibition of DGAT2 is a promising strategy for the treatment of hepatic steatosis and insulin resistance. Here, we identified compound 122 as a potent and selective inhibitor of human DGAT2, which appeared to act competitively against oleoyl-CoA in vitro. The selective inhibition of DGAT2 was also confirmed by the reductions in enzymatic activity and de novo TG synthesis in DGAT2-overexpressing HEK293 cells and hepatic cells HepG2. Compound 122, as a newly identified inhibitor of DGAT2, will be useful for the research on DGAT2-related lipid metabolism as well as the development of therapeutic drug for several metabolic diseases.